Skip to main content
Top
Published in: Head and Neck Pathology 4/2011

01-12-2011 | Case Report

EBV-Positive Plasmacytoma of the Submandibular Gland—Report of a Rare Case with Molecular Genetic Characterization

Authors: Benedict Yan, Soo Yong Tan, Ee Xuan Yau, Siok Bian Ng, Fredrik Petersson

Published in: Head and Neck Pathology | Issue 4/2011

Login to get access

Abstract

Plasmacytomas are differentiated plasma cell tumors that present as a mass lesion in osseous or extraosseous sites. Although the most common site for extramedullary plasmacytomas (EMP) is in the upper respiratory tract, plasmacytomas initially presenting as salivary gland masses are very uncommon. We describe a case of an EBV-positive plasmacytoma presenting as a 7.7 cm submandibular mass in an elderly immunocompetent man which displayed an abundance of “naked nuclei” on fine needle aspiration cytology. The tumor showed lambda light chain restriction and positive expression for CD38, MUM1 and EBER. Subsequent investigation for myeloma revealed absence of M-protein and end-organ damage, except for a lytic lesion in the radial bone. An extensive fluorescent in situ hybridization analysis showed the tumor to be negative for the t(4;14) FGFR3/IGH translocation as well as translocations involving the IGH, IGL, IGK, CCND1, BCL2, BCL6 and C-MYC genes. KRAS genetic analysis did not reveal any mutations of codons 12, 13 and 61.
Literature
1.
go back to reference Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141–51.PubMedCrossRef Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141–51.PubMedCrossRef
2.
go back to reference Pang NK, Nga ME, Chin SY, et al. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Cytopathology 2010. Pang NK, Nga ME, Chin SY, et al. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Cytopathology 2010.
3.
go back to reference Batsakis JG, Medeiros JL, Luna MA, et al. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol. 2002;6:129–40.PubMedCrossRef Batsakis JG, Medeiros JL, Luna MA, et al. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol. 2002;6:129–40.PubMedCrossRef
4.
go back to reference Sarin H, Manucha V, Verma K. Extramedullary plasmacytoma, a report of five cases diagnosed by FNAC. Cytopathology. 2009;20:328–31.PubMedCrossRef Sarin H, Manucha V, Verma K. Extramedullary plasmacytoma, a report of five cases diagnosed by FNAC. Cytopathology. 2009;20:328–31.PubMedCrossRef
5.
go back to reference Bayer-Garner IB, Joseph L, Sanderson RD, et al. Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma. J Cutan Pathol. 2003;30:18–22.PubMedCrossRef Bayer-Garner IB, Joseph L, Sanderson RD, et al. Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma. J Cutan Pathol. 2003;30:18–22.PubMedCrossRef
6.
go back to reference Bayer-Garner IB, Sanderson RD, Dhodapkar MV, et al. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol. 2001;14:1052–8.PubMedCrossRef Bayer-Garner IB, Sanderson RD, Dhodapkar MV, et al. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol. 2001;14:1052–8.PubMedCrossRef
7.
go back to reference Jourdan M, Ferlin M, Legouffe E, et al. The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br J Haematol. 1998;100:637–46.PubMedCrossRef Jourdan M, Ferlin M, Legouffe E, et al. The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br J Haematol. 1998;100:637–46.PubMedCrossRef
8.
go back to reference Aref S, Goda T, El-Sherbiny M. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors. Hematology. 2003;8:221–8.PubMedCrossRef Aref S, Goda T, El-Sherbiny M. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors. Hematology. 2003;8:221–8.PubMedCrossRef
9.
go back to reference Ng SB, Khoury JD. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist. Adv Anat Pathol. 2009;16:40–55.PubMedCrossRef Ng SB, Khoury JD. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist. Adv Anat Pathol. 2009;16:40–55.PubMedCrossRef
10.
go back to reference Tomita Y, Ohsawa M, Hashimoto M, et al. Plasmacytoma of the gastrointestinal tract in Korea: higher incidence than in Japan and Epstein-Barr virus association. Oncology. 1998;55:27–32.PubMedCrossRef Tomita Y, Ohsawa M, Hashimoto M, et al. Plasmacytoma of the gastrointestinal tract in Korea: higher incidence than in Japan and Epstein-Barr virus association. Oncology. 1998;55:27–32.PubMedCrossRef
11.
go back to reference Aguilera NS, Kapadia SB, Nalesnik MA, et al. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol. 1995;8:503–8.PubMed Aguilera NS, Kapadia SB, Nalesnik MA, et al. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol. 1995;8:503–8.PubMed
12.
go back to reference Criteria for the classification of monoclonal gammopathies. Multiple myeloma and related disorders: a report of the International myeloma working group. Br J Haematol. 2003;121:749–57.CrossRef Criteria for the classification of monoclonal gammopathies. Multiple myeloma and related disorders: a report of the International myeloma working group. Br J Haematol. 2003;121:749–57.CrossRef
13.
go back to reference Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736–47.PubMedCrossRef Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736–47.PubMedCrossRef
14.
go back to reference Valera A, Balague O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686–94.PubMed Valera A, Balague O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686–94.PubMed
15.
go back to reference Richendollar BG, Hsi ED, Cook JR. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features. Am J Clin Pathol. 2009;132:581–8.PubMedCrossRef Richendollar BG, Hsi ED, Cook JR. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features. Am J Clin Pathol. 2009;132:581–8.PubMedCrossRef
16.
go back to reference Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal. 2007;12:E479–85.PubMed Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal. 2007;12:E479–85.PubMed
17.
go back to reference Kojima M, Shimizu K, Masawa N. Incidental MALT type lymphoma exhibiting prominent plasma cell differentiation associated with Hashimoto’s thyroiditis. A two case report. Head Neck Pathol. 2009;3:27–30.CrossRef Kojima M, Shimizu K, Masawa N. Incidental MALT type lymphoma exhibiting prominent plasma cell differentiation associated with Hashimoto’s thyroiditis. A two case report. Head Neck Pathol. 2009;3:27–30.CrossRef
18.
go back to reference Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004;64:1546–58.PubMedCrossRef Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004;64:1546–58.PubMedCrossRef
19.
go back to reference Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood. 2002;99:2185–91.PubMedCrossRef Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood. 2002;99:2185–91.PubMedCrossRef
20.
go back to reference Bink K, Haralambieva E, Kremer M, et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica. 2008;93:623–6.PubMedCrossRef Bink K, Haralambieva E, Kremer M, et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica. 2008;93:623–6.PubMedCrossRef
21.
go back to reference Smadja NV, Fruchart C, Isnard F, et al. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia. 1998;12:960–9.PubMedCrossRef Smadja NV, Fruchart C, Isnard F, et al. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia. 1998;12:960–9.PubMedCrossRef
22.
go back to reference Rasmussen T, Kuehl M, Lodahl M, et al. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood. 2005;105:317–23.PubMedCrossRef Rasmussen T, Kuehl M, Lodahl M, et al. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood. 2005;105:317–23.PubMedCrossRef
23.
go back to reference Bezieau S, Devilder MC, Avet-Loiseau H, et al. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat. 2001;18:212–24.PubMedCrossRef Bezieau S, Devilder MC, Avet-Loiseau H, et al. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat. 2001;18:212–24.PubMedCrossRef
24.
go back to reference Chng WJ, Gonzalez-Paz N, Price-Troska T, et al. Clinical and biological significance of RAS mutations in multiple myeloma. Leukemia. 2008;22:2280–4.PubMedCrossRef Chng WJ, Gonzalez-Paz N, Price-Troska T, et al. Clinical and biological significance of RAS mutations in multiple myeloma. Leukemia. 2008;22:2280–4.PubMedCrossRef
25.
go back to reference Dores GM, Landgren O, McGlynn KA, et al. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004. Br J Haematol. 2009;144:86–94.PubMedCrossRef Dores GM, Landgren O, McGlynn KA, et al. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004. Br J Haematol. 2009;144:86–94.PubMedCrossRef
26.
27.
go back to reference Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007;110:972–8.PubMedCrossRef Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007;110:972–8.PubMedCrossRef
28.
go back to reference d’Amore F, Johansen P, Houmand A, et al. Epstein-Barr virus genome in non-Hodgkin’s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood. 1996;87:1045–55.PubMed d’Amore F, Johansen P, Houmand A, et al. Epstein-Barr virus genome in non-Hodgkin’s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood. 1996;87:1045–55.PubMed
Metadata
Title
EBV-Positive Plasmacytoma of the Submandibular Gland—Report of a Rare Case with Molecular Genetic Characterization
Authors
Benedict Yan
Soo Yong Tan
Ee Xuan Yau
Siok Bian Ng
Fredrik Petersson
Publication date
01-12-2011
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 4/2011
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-011-0257-z

Other articles of this Issue 4/2011

Head and Neck Pathology 4/2011 Go to the issue